MEASUREMENT OF HYDROGEN SULFIDE DURING BREATH TEST
DK3586131T3Active Publication Date: 2026-06-29CEDARS SINAI MEDICAL CENT
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- DK2018758133T
- Authority / Receiving Office
- DK · DK
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-02-23
- Filing Date
- 2018-02-23
- Publication Date
- 2026-06-29
- Estimated Expiration
- 2038-02-23
AI Technical Summary
Technical Problem
Current breath tests for small intestinal bacterial overgrowth (SIBO) do not include hydrogen sulfide (H2S) measurements, which are associated with specific clinical symptoms like diarrhea, fatigue, abdominal pain, and bowel urgency, limiting their diagnostic capabilities.
Method used
Incorporating hydrogen sulfide (H2S) measurement in breath tests to diagnose and treat H2S-positive conditions such as SIBO, diarrhea, fatigue, abdominal pain, and bowel urgency by administering treatments like rifaximin based on H2S levels in biological samples.
Benefits of technology
Enhances the diagnostic accuracy for H2S-related conditions and provides targeted treatment options, reducing symptom severity and improving patient outcomes.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.